BCL3 anticorps (AA 300-400)
Aperçu rapide pour BCL3 anticorps (AA 300-400) (ABIN6137509)
Antigène
Voir toutes BCL3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 300-400
-
Séquence
- ANVNAQMYSG SSALHSASGR GLLPLVRTLV RSGADSSLKN CHNDTPLMVA RSRRVIDILR GKATRPASTS QPDPSPDRSA NTSPESSSRL SSNGLLSASP S
-
Réactivité croisée
- Humain, Souris, Rat
-
Attributs du produit
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogène
- A synthetic peptide corresponding to a sequence within amino acids 300-400 of human BCL3 (NP_005169.2).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000,IF,1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
-
Autre désignation
- BCL3
-
Sujet
- This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B.,BCL3,BCL4,D19S37,Epigenetics & Nuclear Signaling,Transcription Factors,Cancer,Cell Biology & Developmental Biology,Apoptosis,Immunology & Inflammation,NF-kB Signaling Pathway,BCL3
-
Poids moléculaire
- 47 kDa
-
ID gène
- 602
-
UniProt
- P20749
-
Pathways
- Signalisation NF-kappaB, Maintenance of Protein Location, Protein targeting to Nucleus
Antigène
-